Navigation Links
NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
Date:11/30/2009

ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the 21st Annual Health Care Conference 2009 on December 2, 2009 at 12:30 pm local time at The New York Palace, New York. Novavax will provide an overview of the company's business strategy, research and development progress and upcoming milestones. A link to the live audio only presentation can be accessed via the Company website at www.novavax.com under the Investors tab. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

About the Piper Jaffray Healthcare Conference

Piper Jaffray hosts several client conferences and events each year focusing on the consumer, health care, financial services, alternative energy and technology sectors. The goal of each conference is to bring together key industry executives, investors and Piper Jaffray professionals to provide multiple perspectives, investigate critical trends and identify the leaders in the markets that are driving the economy.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additio
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. Novavax Reports First Quarter 2008 Financial Results
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax to Join Russell 3000 Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Diego, CA (PRWEB) July 30, 2014 ... contract from the U.S. Environmental Protection Agency (EPA). ... expertise in developmental toxicity models, including tests designed ... neuron formation and the formation of connections between ... Inhibition of neurodifferentiation and synapse formation by environmental ...
(Date:7/29/2014)... 30, 2014 “PharmaSphere: Emerging Biotech ... Venture Capital Funding” report provides in-depth analysis of ... equity and venture capital segments of the financial ... to have significant impact on the future of ... Furthermore, the report identifies regions of the world ...
(Date:7/29/2014)... a particle be separated from its properties? On July ... the results of the first Cheshire Cat experiment, separating ... University in Orange, CA, and Vienna University of Technology. ... a grin," thought Alice in Wonderland, "but a grin ... ever saw in my life!" Alice,s surprise stems from ...
(Date:7/29/2014)... Second generation biofuels are a viable solution to the ... natural gas is very cheap, this is affecting the biofuels ... as they could be in comparison to natural gas. ... it difficult for renewable energy developers to get the economics ... these reasons, certain companies have shifted their focused within renewable ...
Breaking Biology Technology:U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2
... April 27 Cellectricon, a leading,provider of ... announced,its collaboration with BioFocus DPI, a contract ... screening. BioFocus DPI will utilize,Cellectricon,s Dynaflow(R)HT, a ... increase its electrophysiology-based screening capacity, particularly,for fast ...
... SALEM, Mass., April 27 LaVoie Group, a life ... been selected as investor relations agency of record for ... of LaVoie Group, commented, "Pegasus has the opportunity to ... The Company is changing the standard of care ...
... MISSISSAUGA, ON, April 24 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: ... will succeed Terrance H. Gregg as Chairman of its Board ... Gregg,s resignation from Vasogen,s Board is due to the requirements ... , Dr. Smith, a Vasogen Board member since 1998, is ...
Cached Biology Technology:Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery 2LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster 2Vasogen Appoints Dr. Eldon Smith Chairman 2Vasogen Appoints Dr. Eldon Smith Chairman 3
(Date:7/30/2014)... paper published online today in the journal Scientific ... Evan Kodra and Auroop Ganguly found that while global ... in temperature extremes. For instance, while each year,s average ... will also tend to fall within a wider range ... currently being observed. This means that even as overall ...
(Date:7/29/2014)... restaurant, don,t blame yourself; blame the menu. What you ... and more to do with a menu,s layout and descriptions. ... 300 diners, the Cornell study published this month in the ... it comes to what you order for dinner, two things ... you imagine it will taste. , First, any food item ...
(Date:7/29/2014)... on the remote UK overseas territory of Ascension Island, ... undergoing something of a renaissance. , Writing in the ... University of Exeter and Ascension Island Government Conservation Department ... the remote South Atlantic outpost has increased by more ... 1970s. As many as 24,000 nests are now estimated ...
Breaking Biology News(10 mins):Big data confirms climate extremes are here to stay 2Menu secrets that can make you slim by design 2Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2
... 2013 Studies have shown that about 10 percent ... an elevated resting energy expenditure (REE). Their bodies use ... and breathing. Most studies have been conducted in men ... sizes. A team of researchers has sought to rectify ...
... Disease-resistant wheat developed over the past half century helped ensure ... researchers from the University of Minnesota warns in a new ... new strains of a deadly fungal disease could leave millions ... the current edition of the journal Science , examines ...
... , CHARLOTTE, N.C. April 15, 2013 As the ... to alternative energy solutions, UNC Charlotte researcher Deborah Strumsky is ... investments for the array of solar energy technologies that are ... of complex, inter-related factors when building their retirement funds ...
Cached Biology News:Women with HIV shown to have elevated resting energy expenditure 2Without adequate funding, deadly wheat disease could threaten global food supplies 2UNC Charlotte researcher leads effort to forecast optimal energy investments 2
... Edwards (1996) • Provides key ... immunoassays, including RIA, ELISA and ... the photoluminescent and chemiluminescent labels ... also given on assay design ...
... A.P. Johnstone and ... This book describes step-by-step ... of immunologically relevant molecules, ... as highly specific analytical ...
Request Info...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
Biology Products: